Concepedia

Magdalena Benda

MB

4

Publications

463

Citations

4

H-Index

2021

Active since

Affiliations

Innsbruck Medical University(Current)

Landeskrankenhaus Feldkirch

University of Zurich

Private University in the Principality of Liechtenstein

Magdalena Benda is an author at Innsbruck Medical University specializing in medicine, cardiovascular pharmacology, and t cell immunity.

ORCID

Top concepts

Publications per year

2021–2022

4

Publications

4

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

, , +10

The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients

Emanuel Zitt, Tamara Davidovic, Judith Schimpf et al. · Frontiers in Immunology · 2021 · 69 citations · Full text

Serological SARS‐CoV‐2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID‐19 vaccine in haematological and oncological patients

Magdalena Benda, Beatrix Mutschlechner, Hanno Ulmer et al. · British Journal of Haematology · 2021 · 57 citations · Full text

Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID‐19 vaccine in haemato‐oncological patients with no antibody response

Patrick Reimann, Hanno Ulmer, Beatrix Mutschlechner et al. · British Journal of Haematology · 2021 · 41 citations · Full text

, , +25

Rows per page

1–4 of 4